These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15876898

  • 1. Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study.
    Nickel MK, Nickel C, Muehlbacher M, Leiberich PK, Kaplan P, Lahmann C, Tritt K, Krawczyk J, Kettler C, Egger C, Rother WK, Loew TH.
    J Clin Psychopharmacol; 2005 Jun; 25(3):211-7. PubMed ID: 15876898
    [Abstract] [Full Text] [Related]

  • 2. Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation.
    Egger C, Muehlbacher M, Schatz M, Nickel M.
    J Clin Psychopharmacol; 2007 Oct; 27(5):475-8. PubMed ID: 17873679
    [Abstract] [Full Text] [Related]

  • 3. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.
    Narula PK, Rehan HS, Unni KE, Gupta N.
    Schizophr Res; 2010 May; 118(1-3):218-23. PubMed ID: 20207521
    [Abstract] [Full Text] [Related]

  • 4. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.
    Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P.
    Clin J Pain; 2006 May; 22(6):526-31. PubMed ID: 16788338
    [Abstract] [Full Text] [Related]

  • 5. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.
    Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH.
    J Clin Psychiatry; 2004 Nov; 65(11):1515-9. PubMed ID: 15554765
    [Abstract] [Full Text] [Related]

  • 6. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.
    Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C.
    J Clin Psychopharmacol; 2006 Feb; 26(1):61-6. PubMed ID: 16415708
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group.
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.
    Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.
    Biol Psychiatry; 2005 Mar 01; 57(5):495-9. PubMed ID: 15737664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia.
    Kim JH, Yim SJ, Nam JH.
    Schizophr Res; 2006 Feb 15; 82(1):115-7. PubMed ID: 16326074
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH.
    Am J Psychiatry; 2008 Mar 15; 165(3):352-8. PubMed ID: 18245179
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.